In vitro anticancer evaluation of Enceleamycin A and its underlying mechanism Article Swipe

PDF

Abujunaid Habib Khan , Sushma Pradeep , Syed G. Dastager ·

YOU? · · 2023 · Open Access · · DOI: https://doi.org/10.1039/d3ra06204j

Enceleamycin A a candidate molecule for treating TNBC cells by targeting the AKT2 signaling pathway.

Related Topics

Triple-Negative Breast Cancer

Concepts

AKT2 Annexin Cytotoxicity In silico In vitro Chemistry Cancer cell Docking (animal) Cancer research Intracellular Apoptosis IC50 Triple-negative breast cancer Paclitaxel Pharmacology Cancer Breast cancer Biology Biochemistry Medicine PI3K/AKT/mTOR pathway AKT1 Internal medicine Gene Nursing

Metadata

Type: article
Language: en
Landing Page: https://doi.org/10.1039/d3ra06204j
PDF: https://pubs.rsc.org/en/content/articlepdf/2023/ra/d3ra06204j
OA Status: gold
Cited By: 1
References: 57
Related Works: 10
OpenAlex ID: https://openalex.org/W4388917270

All OpenAlex metadata

Raw OpenAlex JSON

OpenAlex ID: https://openalex.org/W4388917270

Canonical identifier for this work in OpenAlex
DOI: https://doi.org/10.1039/d3ra06204j

Digital Object Identifier
Title: In vitro anticancer evaluation of Enceleamycin A and its underlying mechanism

Work title
Type: article

OpenAlex work type
Language: en

Primary language
Publication year: 2023

Year of publication
Publication date: 2023-01-01

Full publication date if available
Authors: Abujunaid Habib Khan, Sushma Pradeep, Syed G. Dastager

List of authors in order
Landing page: https://doi.org/10.1039/d3ra06204j

Publisher landing page
PDF URL: https://pubs.rsc.org/en/content/articlepdf/2023/ra/d3ra06204j

Direct link to full text PDF
Open access: Yes

Whether a free full text is available
OA status: gold

Open access status per OpenAlex
OA URL: https://pubs.rsc.org/en/content/articlepdf/2023/ra/d3ra06204j

Direct OA link when available
Concepts: AKT2, Annexin, Cytotoxicity, In silico, In vitro, Chemistry, Cancer cell, Docking (animal), Cancer research, Intracellular, Apoptosis, IC50, Triple-negative breast cancer, Paclitaxel, Pharmacology, Cancer, Breast cancer, Biology, Biochemistry, Medicine, PI3K/AKT/mTOR pathway, AKT1, Internal medicine, Gene, Nursing

Top concepts (fields/topics) attached by OpenAlex
Cited by: 1

Total citation count in OpenAlex
Citations by year (recent): 2024: 1

Per-year citation counts (last 5 years)
References (count): 57

Number of works referenced by this work
Related works (count): 10

Other works algorithmically related by OpenAlex

Full payload

id	https://openalex.org/W4388917270
doi	https://doi.org/10.1039/d3ra06204j
ids.doi	https://doi.org/10.1039/d3ra06204j
ids.pmid	https://pubmed.ncbi.nlm.nih.gov/38019992
ids.openalex	https://openalex.org/W4388917270
fwci	0.32412443
type	article
title	In vitro anticancer evaluation of Enceleamycin A and its underlying mechanism
biblio.issue	48
biblio.volume	13
biblio.last_page	34193
biblio.first_page	34183
grants[0].funder	https://openalex.org/F4320320767
grants[0].award_id
grants[0].funder_display_name	University Grants Commission
topics[0].id	https://openalex.org/T12356
topics[0].field.id	https://openalex.org/fields/30
topics[0].field.display_name	Pharmacology, Toxicology and Pharmaceutics
topics[0].score	1.0
topics[0].domain.id	https://openalex.org/domains/1
topics[0].domain.display_name	Life Sciences
topics[0].subfield.id	https://openalex.org/subfields/3005
topics[0].subfield.display_name	Toxicology
topics[0].display_name	Bioactive Compounds and Antitumor Agents
topics[1].id	https://openalex.org/T11845
topics[1].field.id	https://openalex.org/fields/13
topics[1].field.display_name	Biochemistry, Genetics and Molecular Biology
topics[1].score	0.9994999766349792
topics[1].domain.id	https://openalex.org/domains/1
topics[1].domain.display_name	Life Sciences
topics[1].subfield.id	https://openalex.org/subfields/1312
topics[1].subfield.display_name	Molecular Biology
topics[1].display_name	Cancer therapeutics and mechanisms
topics[2].id	https://openalex.org/T10274
topics[2].field.id	https://openalex.org/fields/16
topics[2].field.display_name	Chemistry
topics[2].score	0.9771000146865845
topics[2].domain.id	https://openalex.org/domains/3
topics[2].domain.display_name	Physical Sciences
topics[2].subfield.id	https://openalex.org/subfields/1605
topics[2].subfield.display_name	Organic Chemistry
topics[2].display_name	Synthesis and biological activity
funders[0].id	https://openalex.org/F4320320767
funders[0].ror	https://ror.org/04p800546
funders[0].display_name	University Grants Commission
is_xpac	False
apc_list.value	850
apc_list.currency	GBP
apc_list.value_usd	1042
apc_paid.value	850
apc_paid.currency	GBP
apc_paid.value_usd	1042
concepts[0].id	https://openalex.org/C88216763
concepts[0].level	5
concepts[0].score	0.7793897390365601
concepts[0].wikidata	https://www.wikidata.org/wiki/Q4652205
concepts[0].display_name	AKT2
concepts[1].id	https://openalex.org/C88634738
concepts[1].level	3
concepts[1].score	0.6669735908508301
concepts[1].wikidata	https://www.wikidata.org/wiki/Q24769543
concepts[1].display_name	Annexin
concepts[2].id	https://openalex.org/C109316439
concepts[2].level	3
concepts[2].score	0.5843892693519592
concepts[2].wikidata	https://www.wikidata.org/wiki/Q246181
concepts[2].display_name	Cytotoxicity
concepts[3].id	https://openalex.org/C2775905019
concepts[3].level	3
concepts[3].score	0.5732991099357605
concepts[3].wikidata	https://www.wikidata.org/wiki/Q192572
concepts[3].display_name	In silico
concepts[4].id	https://openalex.org/C202751555
concepts[4].level	2
concepts[4].score	0.5358530282974243
concepts[4].wikidata	https://www.wikidata.org/wiki/Q221681
concepts[4].display_name	In vitro
concepts[5].id	https://openalex.org/C185592680
concepts[5].level	0
concepts[5].score	0.5353308916091919
concepts[5].wikidata	https://www.wikidata.org/wiki/Q2329
concepts[5].display_name	Chemistry
concepts[6].id	https://openalex.org/C96232424
concepts[6].level	3
concepts[6].score	0.5343536138534546
concepts[6].wikidata	https://www.wikidata.org/wiki/Q4118072
concepts[6].display_name	Cancer cell
concepts[7].id	https://openalex.org/C41685203
concepts[7].level	2
concepts[7].score	0.5285983085632324
concepts[7].wikidata	https://www.wikidata.org/wiki/Q1974042
concepts[7].display_name	Docking (animal)
concepts[8].id	https://openalex.org/C502942594
concepts[8].level	1
concepts[8].score	0.5092655420303345
concepts[8].wikidata	https://www.wikidata.org/wiki/Q3421914
concepts[8].display_name	Cancer research
concepts[9].id	https://openalex.org/C79879829
concepts[9].level	2
concepts[9].score	0.4843226969242096
concepts[9].wikidata	https://www.wikidata.org/wiki/Q5571762
concepts[9].display_name	Intracellular
concepts[10].id	https://openalex.org/C190283241
concepts[10].level	2
concepts[10].score	0.4646688401699066
concepts[10].wikidata	https://www.wikidata.org/wiki/Q14599311
concepts[10].display_name	Apoptosis
concepts[11].id	https://openalex.org/C2777752497
concepts[11].level	3
concepts[11].score	0.46014153957366943
concepts[11].wikidata	https://www.wikidata.org/wiki/Q286779
concepts[11].display_name	IC50
concepts[12].id	https://openalex.org/C2780110267
concepts[12].level	4
concepts[12].score	0.4444465637207031
concepts[12].wikidata	https://www.wikidata.org/wiki/Q7843332
concepts[12].display_name	Triple-negative breast cancer
concepts[13].id	https://openalex.org/C2777292972
concepts[13].level	3
concepts[13].score	0.43395522236824036
concepts[13].wikidata	https://www.wikidata.org/wiki/Q423762
concepts[13].display_name	Paclitaxel
concepts[14].id	https://openalex.org/C98274493
concepts[14].level	1
concepts[14].score	0.383756548166275
concepts[14].wikidata	https://www.wikidata.org/wiki/Q128406
concepts[14].display_name	Pharmacology
concepts[15].id	https://openalex.org/C121608353
concepts[15].level	2
concepts[15].score	0.3360294699668884
concepts[15].wikidata	https://www.wikidata.org/wiki/Q12078
concepts[15].display_name	Cancer
concepts[16].id	https://openalex.org/C530470458
concepts[16].level	3
concepts[16].score	0.32856059074401855
concepts[16].wikidata	https://www.wikidata.org/wiki/Q128581
concepts[16].display_name	Breast cancer
concepts[17].id	https://openalex.org/C86803240
concepts[17].level	0
concepts[17].score	0.2515338659286499
concepts[17].wikidata	https://www.wikidata.org/wiki/Q420
concepts[17].display_name	Biology
concepts[18].id	https://openalex.org/C55493867
concepts[18].level	1
concepts[18].score	0.22603851556777954
concepts[18].wikidata	https://www.wikidata.org/wiki/Q7094
concepts[18].display_name	Biochemistry
concepts[19].id	https://openalex.org/C71924100
concepts[19].level	0
concepts[19].score	0.20114487409591675
concepts[19].wikidata	https://www.wikidata.org/wiki/Q11190
concepts[19].display_name	Medicine
concepts[20].id	https://openalex.org/C86554907
concepts[20].level	3
concepts[20].score	0.09831136465072632
concepts[20].wikidata	https://www.wikidata.org/wiki/Q285613
concepts[20].display_name	PI3K/AKT/mTOR pathway
concepts[21].id	https://openalex.org/C154137905
concepts[21].level	4
concepts[21].score	0.07541316747665405
concepts[21].wikidata	https://www.wikidata.org/wiki/Q17816452
concepts[21].display_name	AKT1
concepts[22].id	https://openalex.org/C126322002
concepts[22].level	1
concepts[22].score	0.06032294034957886
concepts[22].wikidata	https://www.wikidata.org/wiki/Q11180
concepts[22].display_name	Internal medicine
concepts[23].id	https://openalex.org/C104317684
concepts[23].level	2
concepts[23].score	0.0
concepts[23].wikidata	https://www.wikidata.org/wiki/Q7187
concepts[23].display_name	Gene
concepts[24].id	https://openalex.org/C159110408
concepts[24].level	1
concepts[24].score	0.0
concepts[24].wikidata	https://www.wikidata.org/wiki/Q121176
concepts[24].display_name	Nursing
keywords[0].id	https://openalex.org/keywords/akt2
keywords[0].score	0.7793897390365601
keywords[0].display_name	AKT2
keywords[1].id	https://openalex.org/keywords/annexin
keywords[1].score	0.6669735908508301
keywords[1].display_name	Annexin
keywords[2].id	https://openalex.org/keywords/cytotoxicity
keywords[2].score	0.5843892693519592
keywords[2].display_name	Cytotoxicity
keywords[3].id	https://openalex.org/keywords/in-silico
keywords[3].score	0.5732991099357605
keywords[3].display_name	In silico
keywords[4].id	https://openalex.org/keywords/in-vitro
keywords[4].score	0.5358530282974243
keywords[4].display_name	In vitro
keywords[5].id	https://openalex.org/keywords/chemistry
keywords[5].score	0.5353308916091919
keywords[5].display_name	Chemistry
keywords[6].id	https://openalex.org/keywords/cancer-cell
keywords[6].score	0.5343536138534546
keywords[6].display_name	Cancer cell
keywords[7].id	https://openalex.org/keywords/docking
keywords[7].score	0.5285983085632324
keywords[7].display_name	Docking (animal)
keywords[8].id	https://openalex.org/keywords/cancer-research
keywords[8].score	0.5092655420303345
keywords[8].display_name	Cancer research
keywords[9].id	https://openalex.org/keywords/intracellular
keywords[9].score	0.4843226969242096
keywords[9].display_name	Intracellular
keywords[10].id	https://openalex.org/keywords/apoptosis
keywords[10].score	0.4646688401699066
keywords[10].display_name	Apoptosis
keywords[11].id	https://openalex.org/keywords/ic50
keywords[11].score	0.46014153957366943
keywords[11].display_name	IC50
keywords[12].id	https://openalex.org/keywords/triple-negative-breast-cancer
keywords[12].score	0.4444465637207031
keywords[12].display_name	Triple-negative breast cancer
keywords[13].id	https://openalex.org/keywords/paclitaxel
keywords[13].score	0.43395522236824036
keywords[13].display_name	Paclitaxel
keywords[14].id	https://openalex.org/keywords/pharmacology
keywords[14].score	0.383756548166275
keywords[14].display_name	Pharmacology
keywords[15].id	https://openalex.org/keywords/cancer
keywords[15].score	0.3360294699668884
keywords[15].display_name	Cancer
keywords[16].id	https://openalex.org/keywords/breast-cancer
keywords[16].score	0.32856059074401855
keywords[16].display_name	Breast cancer
keywords[17].id	https://openalex.org/keywords/biology
keywords[17].score	0.2515338659286499
keywords[17].display_name	Biology
keywords[18].id	https://openalex.org/keywords/biochemistry
keywords[18].score	0.22603851556777954
keywords[18].display_name	Biochemistry
keywords[19].id	https://openalex.org/keywords/medicine
keywords[19].score	0.20114487409591675
keywords[19].display_name	Medicine
keywords[20].id	https://openalex.org/keywords/pi3k/akt/mtor-pathway
keywords[20].score	0.09831136465072632
keywords[20].display_name	PI3K/AKT/mTOR pathway
keywords[21].id	https://openalex.org/keywords/akt1
keywords[21].score	0.07541316747665405
keywords[21].display_name	AKT1
keywords[22].id	https://openalex.org/keywords/internal-medicine
keywords[22].score	0.06032294034957886
keywords[22].display_name	Internal medicine
language	en
locations[0].id	doi:10.1039/d3ra06204j
locations[0].is_oa	True
locations[0].source.id	https://openalex.org/S2481244646
locations[0].source.issn	2046-2069
locations[0].source.type	journal
locations[0].source.is_oa	True
locations[0].source.issn_l	2046-2069
locations[0].source.is_core	True
locations[0].source.is_in_doaj	True
locations[0].source.display_name	RSC Advances
locations[0].source.host_organization	https://openalex.org/P4310320556
locations[0].source.host_organization_name	Royal Society of Chemistry
locations[0].source.host_organization_lineage	https://openalex.org/P4310320556
locations[0].license	cc-by-nc
locations[0].pdf_url	https://pubs.rsc.org/en/content/articlepdf/2023/ra/d3ra06204j
locations[0].version	publishedVersion
locations[0].raw_type	journal-article
locations[0].license_id	https://openalex.org/licenses/cc-by-nc
locations[0].is_accepted	True
locations[0].is_published	True
locations[0].raw_source_name	RSC Advances
locations[0].landing_page_url	https://doi.org/10.1039/d3ra06204j
locations[1].id	pmid:38019992
locations[1].is_oa	False
locations[1].source.id	https://openalex.org/S4306525036
locations[1].source.issn
locations[1].source.type	repository
locations[1].source.is_oa	False
locations[1].source.issn_l
locations[1].source.is_core	False
locations[1].source.is_in_doaj	False
locations[1].source.display_name	PubMed
locations[1].source.host_organization	https://openalex.org/I1299303238
locations[1].source.host_organization_name	National Institutes of Health
locations[1].source.host_organization_lineage	https://openalex.org/I1299303238
locations[1].license
locations[1].pdf_url
locations[1].version	publishedVersion
locations[1].raw_type
locations[1].license_id
locations[1].is_accepted	True
locations[1].is_published	True
locations[1].raw_source_name	RSC advances
locations[1].landing_page_url	https://pubmed.ncbi.nlm.nih.gov/38019992
locations[2].id	pmh:oai:pubmedcentral.nih.gov:10663723
locations[2].is_oa	True
locations[2].source.id	https://openalex.org/S2764455111
locations[2].source.issn
locations[2].source.type	repository
locations[2].source.is_oa	False
locations[2].source.issn_l
locations[2].source.is_core	False
locations[2].source.is_in_doaj	False
locations[2].source.display_name	PubMed Central
locations[2].source.host_organization	https://openalex.org/I1299303238
locations[2].source.host_organization_name	National Institutes of Health
locations[2].source.host_organization_lineage	https://openalex.org/I1299303238
locations[2].license
locations[2].pdf_url	https://pmc.ncbi.nlm.nih.gov/articles/PMC10663723/pdf/RA-013-D3RA06204J.pdf
locations[2].version	submittedVersion
locations[2].raw_type	Text
locations[2].license_id
locations[2].is_accepted	False
locations[2].is_published	False
locations[2].raw_source_name	RSC Adv
locations[2].landing_page_url	https://www.ncbi.nlm.nih.gov/pmc/articles/10663723
indexed_in	crossref, doaj, pubmed
authorships[0].author.id	https://openalex.org/A5071538720
authorships[0].author.orcid	https://orcid.org/0009-0008-8086-5325
authorships[0].author.display_name	Abujunaid Habib Khan
authorships[0].countries	IN
authorships[0].affiliations[0].institution_ids	https://openalex.org/I3125981224
authorships[0].affiliations[0].raw_affiliation_string	NCIM-Resource Center, Biochemical Sciences Division, CSIR-National Chemical Laboratory, Pune – 411008, India
authorships[0].affiliations[1].institution_ids	https://openalex.org/I99364266
authorships[0].affiliations[1].raw_affiliation_string	Academy of Scientific and Innovative Research (AcSIR), Ghaziabad – 201002, India
authorships[0].institutions[0].id	https://openalex.org/I99364266
authorships[0].institutions[0].ror	https://ror.org/053rcsq61
authorships[0].institutions[0].type	education
authorships[0].institutions[0].lineage	https://openalex.org/I99364266
authorships[0].institutions[0].country_code	IN
authorships[0].institutions[0].display_name	Academy of Scientific and Innovative Research
authorships[0].institutions[1].id	https://openalex.org/I3125981224
authorships[0].institutions[1].ror	https://ror.org/057mn3690
authorships[0].institutions[1].type	facility
authorships[0].institutions[1].lineage	https://openalex.org/I2799351866, https://openalex.org/I3125981224, https://openalex.org/I4210134808, https://openalex.org/I66760702
authorships[0].institutions[1].country_code	IN
authorships[0].institutions[1].display_name	National Chemical Laboratory
authorships[0].author_position	first
authorships[0].raw_author_name	Abujunaid Khan
authorships[0].is_corresponding	False
authorships[0].raw_affiliation_strings	Academy of Scientific and Innovative Research (AcSIR), Ghaziabad – 201002, India, NCIM-Resource Center, Biochemical Sciences Division, CSIR-National Chemical Laboratory, Pune – 411008, India
authorships[1].author.id	https://openalex.org/A5025225158
authorships[1].author.orcid
authorships[1].author.display_name	Sushma Pradeep
authorships[1].countries	IN
authorships[1].affiliations[0].institution_ids	https://openalex.org/I99364266
authorships[1].affiliations[0].raw_affiliation_string	Academy of Scientific and Innovative Research (AcSIR), Ghaziabad – 201002, India
authorships[1].affiliations[1].institution_ids	https://openalex.org/I3125981224
authorships[1].affiliations[1].raw_affiliation_string	NCIM-Resource Center, Biochemical Sciences Division, CSIR-National Chemical Laboratory, Pune – 411008, India
authorships[1].institutions[0].id	https://openalex.org/I99364266
authorships[1].institutions[0].ror	https://ror.org/053rcsq61
authorships[1].institutions[0].type	education
authorships[1].institutions[0].lineage	https://openalex.org/I99364266
authorships[1].institutions[0].country_code	IN
authorships[1].institutions[0].display_name	Academy of Scientific and Innovative Research
authorships[1].institutions[1].id	https://openalex.org/I3125981224
authorships[1].institutions[1].ror	https://ror.org/057mn3690
authorships[1].institutions[1].type	facility
authorships[1].institutions[1].lineage	https://openalex.org/I2799351866, https://openalex.org/I3125981224, https://openalex.org/I4210134808, https://openalex.org/I66760702
authorships[1].institutions[1].country_code	IN
authorships[1].institutions[1].display_name	National Chemical Laboratory
authorships[1].author_position	middle
authorships[1].raw_author_name	S. Pradeep
authorships[1].is_corresponding	False
authorships[1].raw_affiliation_strings	Academy of Scientific and Innovative Research (AcSIR), Ghaziabad – 201002, India, NCIM-Resource Center, Biochemical Sciences Division, CSIR-National Chemical Laboratory, Pune – 411008, India
authorships[2].author.id	https://openalex.org/A5009439460
authorships[2].author.orcid	https://orcid.org/0000-0002-8316-1242
authorships[2].author.display_name	Syed G. Dastager
authorships[2].countries	IN
authorships[2].affiliations[0].institution_ids	https://openalex.org/I99364266
authorships[2].affiliations[0].raw_affiliation_string	Academy of Scientific and Innovative Research (AcSIR), Ghaziabad – 201002, India
authorships[2].affiliations[1].institution_ids	https://openalex.org/I3125981224
authorships[2].affiliations[1].raw_affiliation_string	NCIM-Resource Center, Biochemical Sciences Division, CSIR-National Chemical Laboratory, Pune – 411008, India
authorships[2].institutions[0].id	https://openalex.org/I99364266
authorships[2].institutions[0].ror	https://ror.org/053rcsq61
authorships[2].institutions[0].type	education
authorships[2].institutions[0].lineage	https://openalex.org/I99364266
authorships[2].institutions[0].country_code	IN
authorships[2].institutions[0].display_name	Academy of Scientific and Innovative Research
authorships[2].institutions[1].id	https://openalex.org/I3125981224
authorships[2].institutions[1].ror	https://ror.org/057mn3690
authorships[2].institutions[1].type	facility
authorships[2].institutions[1].lineage	https://openalex.org/I2799351866, https://openalex.org/I3125981224, https://openalex.org/I4210134808, https://openalex.org/I66760702
authorships[2].institutions[1].country_code	IN
authorships[2].institutions[1].display_name	National Chemical Laboratory
authorships[2].author_position	last
authorships[2].raw_author_name	Syed G. Dastager
authorships[2].is_corresponding	True
authorships[2].raw_affiliation_strings	Academy of Scientific and Innovative Research (AcSIR), Ghaziabad – 201002, India, NCIM-Resource Center, Biochemical Sciences Division, CSIR-National Chemical Laboratory, Pune – 411008, India
has_content.pdf	True
has_content.grobid_xml	True
is_paratext	False
open_access.is_oa	True
open_access.oa_url	https://pubs.rsc.org/en/content/articlepdf/2023/ra/d3ra06204j
open_access.oa_status	gold
open_access.any_repository_has_fulltext	False
created_date	2025-10-10T00:00:00
display_name	In vitro anticancer evaluation of Enceleamycin A and its underlying mechanism
has_fulltext	True
is_retracted	False
updated_date	2025-11-23T05:10:03.516525
primary_topic.id	https://openalex.org/T12356
primary_topic.field.id	https://openalex.org/fields/30
primary_topic.field.display_name	Pharmacology, Toxicology and Pharmaceutics
primary_topic.score	1.0
primary_topic.domain.id	https://openalex.org/domains/1
primary_topic.domain.display_name	Life Sciences
primary_topic.subfield.id	https://openalex.org/subfields/3005
primary_topic.subfield.display_name	Toxicology
primary_topic.display_name	Bioactive Compounds and Antitumor Agents
related_works	https://openalex.org/W3147219444, https://openalex.org/W3149674127, https://openalex.org/W2316397280, https://openalex.org/W2012996470, https://openalex.org/W1963667957, https://openalex.org/W4244054686, https://openalex.org/W1582696369, https://openalex.org/W2034199499, https://openalex.org/W2775544316, https://openalex.org/W2891057236
cited_by_count	1
counts_by_year[0].year	2024
counts_by_year[0].cited_by_count	1
locations_count	3
best_oa_location.id	doi:10.1039/d3ra06204j
best_oa_location.is_oa	True
best_oa_location.source.id	https://openalex.org/S2481244646
best_oa_location.source.issn	2046-2069
best_oa_location.source.type	journal
best_oa_location.source.is_oa	True
best_oa_location.source.issn_l	2046-2069
best_oa_location.source.is_core	True
best_oa_location.source.is_in_doaj	True
best_oa_location.source.display_name	RSC Advances
best_oa_location.source.host_organization	https://openalex.org/P4310320556
best_oa_location.source.host_organization_name	Royal Society of Chemistry
best_oa_location.source.host_organization_lineage	https://openalex.org/P4310320556
best_oa_location.license	cc-by-nc
best_oa_location.pdf_url	https://pubs.rsc.org/en/content/articlepdf/2023/ra/d3ra06204j
best_oa_location.version	publishedVersion
best_oa_location.raw_type	journal-article
best_oa_location.license_id	https://openalex.org/licenses/cc-by-nc
best_oa_location.is_accepted	True
best_oa_location.is_published	True
best_oa_location.raw_source_name	RSC Advances
best_oa_location.landing_page_url	https://doi.org/10.1039/d3ra06204j
primary_location.id	doi:10.1039/d3ra06204j
primary_location.is_oa	True
primary_location.source.id	https://openalex.org/S2481244646
primary_location.source.issn	2046-2069
primary_location.source.type	journal
primary_location.source.is_oa	True
primary_location.source.issn_l	2046-2069
primary_location.source.is_core	True
primary_location.source.is_in_doaj	True
primary_location.source.display_name	RSC Advances
primary_location.source.host_organization	https://openalex.org/P4310320556
primary_location.source.host_organization_name	Royal Society of Chemistry
primary_location.source.host_organization_lineage	https://openalex.org/P4310320556
primary_location.license	cc-by-nc
primary_location.pdf_url	https://pubs.rsc.org/en/content/articlepdf/2023/ra/d3ra06204j
primary_location.version	publishedVersion
primary_location.raw_type	journal-article
primary_location.license_id	https://openalex.org/licenses/cc-by-nc
primary_location.is_accepted	True
primary_location.is_published	True
primary_location.raw_source_name	RSC Advances
primary_location.landing_page_url	https://doi.org/10.1039/d3ra06204j
publication_date	2023-01-01
publication_year	2023
referenced_works	https://openalex.org/W2017464987, https://openalex.org/W2896603322, https://openalex.org/W3128646645, https://openalex.org/W2966613037, https://openalex.org/W3033869790, https://openalex.org/W2523763608, https://openalex.org/W4308638075, https://openalex.org/W2162799606, https://openalex.org/W2103413641, https://openalex.org/W2053206500, https://openalex.org/W2998318498, https://openalex.org/W2595714719, https://openalex.org/W2059221693, https://openalex.org/W2964479247, https://openalex.org/W1811831938, https://openalex.org/W4297314638, https://openalex.org/W2520986797, https://openalex.org/W2904809160, https://openalex.org/W4386213928, https://openalex.org/W2088539874, https://openalex.org/W1965816424, https://openalex.org/W2468676570, https://openalex.org/W125325141, https://openalex.org/W2025030616, https://openalex.org/W2077763739, https://openalex.org/W4225253132, https://openalex.org/W2114918609, https://openalex.org/W3119801561, https://openalex.org/W2123974920, https://openalex.org/W2519786994, https://openalex.org/W4283693058, https://openalex.org/W2171716692, https://openalex.org/W2105668062, https://openalex.org/W4229441482, https://openalex.org/W2954297401, https://openalex.org/W2789748145, https://openalex.org/W2271736303, https://openalex.org/W2044172327, https://openalex.org/W2096286606, https://openalex.org/W2021740841, https://openalex.org/W2009867031, https://openalex.org/W4242372416, https://openalex.org/W2105649494, https://openalex.org/W3199115261, https://openalex.org/W2155758517, https://openalex.org/W4319159815, https://openalex.org/W4211196614, https://openalex.org/W2037788435, https://openalex.org/W1989746642, https://openalex.org/W2972794119, https://openalex.org/W2116561193, https://openalex.org/W1607931568, https://openalex.org/W2593436234, https://openalex.org/W2135732933, https://openalex.org/W1966369019, https://openalex.org/W3081985894, https://openalex.org/W2988920895
referenced_works_count	57
abstract_inverted_index.A	1
abstract_inverted_index.a	2
abstract_inverted_index.by	9
abstract_inverted_index.for	5
abstract_inverted_index.the	11
abstract_inverted_index.AKT2	12
abstract_inverted_index.TNBC	7
abstract_inverted_index.cells	8
abstract_inverted_index.molecule	4
abstract_inverted_index.pathway.	14
abstract_inverted_index.treating	6
abstract_inverted_index.candidate	3
abstract_inverted_index.signaling	13
abstract_inverted_index.targeting	10
abstract_inverted_index.Enceleamycin	0
cited_by_percentile_year.max	94
cited_by_percentile_year.min	90
corresponding_author_ids	https://openalex.org/A5009439460
countries_distinct_count	1
institutions_distinct_count	3
corresponding_institution_ids	https://openalex.org/I3125981224, https://openalex.org/I99364266
sustainable_development_goals[0].id	https://metadata.un.org/sdg/2
sustainable_development_goals[0].score	0.5099999904632568
sustainable_development_goals[0].display_name	Zero hunger
citation_normalized_percentile.value	0.5683882
citation_normalized_percentile.is_in_top_1_percent	False
citation_normalized_percentile.is_in_top_10_percent	False